Skip to main content

Hospital Quality-Control Program Tied to Rise in Heart Failure Deaths

November 30, 2017

By Lisa Rapaport

(Reuters Health) - Financial penalties designed to encourage hospitals to avoid repeat hospitalizations are working, but they’re also associated with higher mortality rates for patients with heart failure, a U.S. study suggests.

The Affordable Care Act (ACA) of 2010 created punishments for hospitals with high rates of readmissions within 30 days of discharge for Medicare patients with three common problems: heart failure, pneumonia and heart attacks. Readmissions are considered a benchmark for the quality of care, and in theory hospitals that do a better job shouldn’t have as many patients returning soon after they’re sent home.

In one respect, the law worked as intended. Researchers examined data on 115,245 heart failure patients hospitalized from 2006 to 2014 and found readmission rates dropped from 20% before the law took effect to 18.4% after penalties kicked in.

But the proportion of patients who died within 30 days of going home increased from 7.2% to 8.6% over that same period. One-year mortality rates climbed from 31.3% to 36.3%.

“Nationwide, there may have been thousands to tens of thousands of extra deaths in patients with heart failure resulting from this policy,” said senior study author Dr. Gregg Fonarow of the David Geffen School of Medicine at the University of California Los Angeles.

“No level of reduction in readmissions or cost savings should be considered adequate justification for this level of potential harm,” Fonarow said by email.

The study wasn’t a controlled experiment designed to prove whether or how reducing readmission rates might influence survival odds for patients with heart failure.

It’s possible, however, that doctors may have made treatment decisions designed to avoid readmissions rather than to give patients the best possible care, Fonarow said.

Doctors might, for example, have postponed sending patients back to the hospital until after the 30-day window for readmission penalties had passed, allowing heart failure to worsen and decreasing survival odds, Fonarow said.

When patients did return to the hospital within that 30-day penalty window, they might have been kept in the emergency department or a general care unit for observation instead of being formally admitted to the hospital, Fonarow added. This might mean some people who needed intensive care or a specialized cardiac unit didn’t end up there.

Article continues on page 2

To calculate shifts in readmission and mortality rates, researchers looked at three distinct time periods: before the ACA, from January 1, 2006 to March 31, 2010; during an ACA implementation period from April 1, 2010 to September 30, 2012; and after readmission penalties kicked in, from October 1, 2012 to December 31, 2014.

The study looked at data from a total of 416 hospitals, but not at how changes in readmission rates were related to mortality rates at specific hospitals, researchers note online November 12 in JAMA Cardiology.

One study that did focus on hospital-level data, published in JAMA in July, got different results, according to its lead author, Dr. Kumar Dharmarajan, chief scientific officer at Clover Health, a San Francisco-based health insurance startup company.

“While we too found slight increases in mortality for heart failure over time, we found that hospitals lowering readmissions tended to lower mortality despite this finding,” Dharmarajan said by email. “Given our results, it is very unclear to me how efforts to lower readmissions could have resulted in harm.”

Other factors during the study period, like hospital closures and an economic downturn that’s made it harder for many people to afford medications, might also explain some of the change in mortality rates, said Dr. Karen Joynt Maddox of Barnes-Jewish Hospital and the Washington University School of Medicine in St. Louis.

“It’s important to note that we’re looking at patterns over a decade across the country, where a lot of things are happening at once,” Maddox, who wasn’t involved in the study, said by email. “We really need more research to understand these findings so we can figure out what to do.”


JAMA Cardiol 2017.

(c) Copyright Thomson Reuters 2017. Click For Restrictions -

For more articles like this, visit the Oncology Resource Center

For articles by First Report Managed Care, click here

To view the First Report Managed Care print issue, click here

Back to Top